FDA Approves Pradaxa for Thromboprevention After Hip Replacement
The FDA this week approved dabigatran (Pradaxa) for prevention of DVT and pulmonary embolism following hip arthroplasty surgery. The approval …
What’s New in Hip Replacement: Level I and II Studies
Every month, JBJS publishes a Specialty Update—a review of the most pertinent and impactful studies published in the orthopaedic literature …
Case Connector “Watch” Cites Trunnion Troubles in Modular Hip Implants
The hip-arthroplasty community currently feels that the advantages gained from head-neck modularity outweigh the risks, but JBJS Case Connector raises …
Stop Smoking Before Joint Replacement—But for How Long?
The July 1, 2015 JBJS contains a database-driven analysis by Duchman et al. of more than 78,000 patients who …
JBJS Classics: The Harris Hip Score
Each m
onth during the coming year, OrthoBuzz will bring you a current commentary on a “classic” article from The …
JBJS Editor’s Choice—Different Findings about Cell Salvage, Pre- and Post-2010
Orthopaedic surgeons have always been interested in limiting blood loss when it comes to major procedures. No procedures are more …
Joint Replacement Associated with Postop Weight Loss in Obese Patients
The relationships between body weight and joint replacement are debated often in the orthopaedic community. Some surgeons are so concerned …
Trunnion Failure Leads to Head-Neck Dissociation in Modular THA
Head
-neck modularity in total hip arthroplasty (THA) components confers several advantages, including intraoperative flexibility and precision that allow surgeons …
Anesthesia for Hip Replacement: General vs Spinal
A large retrospective cohort study analyzing nearly 21,000 patients who underwent primary total hip arthroplasty (THA) found that the 61% …